Welcome to LookChem.com Sign In|Join Free
  • or
4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine, also known as FANA, is a synthetically modified nucleoside with notable antiviral and antitumor properties. 4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine is characterized by the presence of an azido group at the 4'-carbon position and a 2'-deoxy-2'-fluoro-beta-D-arabinouridine moiety, which together contribute to its ability to impede viral replication and curtail the growth of tumor cells. FANA is currently under investigation for its therapeutic potential in treating hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections, as well as a range of cancers. Ongoing research is focused on assessing the safety and efficacy of FANA in clinical trials.

173379-73-2

Post Buying Request

173379-73-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

173379-73-2 Usage

Uses

Used in Antiviral Applications:
4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine is used as an antiviral agent for its potential to treat hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections. 4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine's unique structure allows it to interfere with the replication mechanisms of these viruses, thereby reducing their ability to infect and proliferate within host cells.
Used in Anticancer Applications:
In the field of oncology, 4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine is utilized as an antitumor agent. It has been studied for its potential to inhibit the growth of various types of cancer cells, making it a candidate for cancer treatment. The precise mechanism by which FANA exerts its anticancer effects is an area of active research, with the aim of understanding its impact on tumor cell biology and its potential synergistic effects with existing cancer therapies.
Used in Pharmaceutical Research and Development:
4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinouridine is also used in the pharmaceutical industry as a subject of research and development. Its unique chemical properties and potential therapeutic applications make it a valuable compound for the discovery of new drugs and treatment strategies for viral infections and cancer.
Used in Clinical Trials:
FANA is currently being used in clinical trials to evaluate its safety and efficacy as a therapeutic agent. These trials are essential for determining the appropriate dosages, potential side effects, and overall effectiveness of the compound in treating the targeted diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 173379-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,3,7 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 173379-73:
(8*1)+(7*7)+(6*3)+(5*3)+(4*7)+(3*9)+(2*7)+(1*3)=162
162 % 10 = 2
So 173379-73-2 is a valid CAS Registry Number.

173379-73-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4(1H,3H)-Pyrimidinedione

1.2 Other means of identification

Product number -
Other names 2,4(1H,3H)-Pyrimidinedione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:173379-73-2 SDS

173379-73-2Relevant academic research and scientific papers

Azido nucleosides and nucleotide analogs

-

Page/Page column 100; 101, (2016/06/13)

Disclosed herein are 4′-azido-substituted nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of 4′-azido-substituted nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a 4′-azido-substituted nucleoside, a nucleotide and/or an analog thereof. Examples of viral infections include a respiratory syncytial viral (RSV) and influenza infection.

3-methyl uridine and 4-methyl cytidine nucleoside compound, synthetic method and its pharmaceutical use

-

Paragraph 0025; 0057, (2016/10/08)

The invention discloses a 3-methyluridine and 4-methylcytidine nucleosides compound and a synthesis method and pharmaceutical application thereof, belonging to the field of medicinal chemistry. The compound has a structural formula as shown in the specification. The compound has the effects of simultaneously modifying sugar rings and basic groups, increasing the activity of the compound and reducing the toxicity, provides a good application prospect for development of like medicines and can be applied to preparation of anti-HBV (Hepatitis B virus) medicines. The synthesis method is simple and feasible and provides conditions for mass synthesis of the compound.

Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection

Yang, Qinghua,Kang, Jinfeng,Zheng, Liyun,Wang, Xue-Jun,Wan, Na,Wu, Jie,Qiao, Yan,Niu, Pengfei,Wang, Sheng-Qi,Peng, Youmei,Wang, Qingduan,Yu, Wenquan,Chang, Junbiao

supporting information, p. 3693 - 3703 (2015/05/27)

A series of 4-substituted fluoronucleosides have been synthesized in order to address the toxicity issue of the parent compound 7, and after in vitro evaluation, the cyclopropylamino analog 1f was selected for in vivo study. In mice, this compound exhibit

The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: The discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′,2′-difluorocytidine

Smith, David B.,Kalayanov, Genadiy,Sund, Christian,Winqvist, Anna,Maltseva, Tatiana,Leveque, Vincent J.-P.,Rajyaguru, Sonal,Le Pogam, Sophie,Najera, Isabel,Benkestock, Kurt,Zhou, Xiao-Xiong,Kaiser, Ann C.,Maag, Hans,Cammack, Nick,Martin, Joseph A.,Swallow, Steven,Johansson, Nils Gunnar,Klumpp, Klaus,Smith, Mark

experimental part, p. 2971 - 2978 (2010/02/28)

The discovery of 4′-azidocytidine (3) (R1479) (J. Biol. Chem. 2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 μM), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the

2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS

-

Page/Page column 64; 66, (2009/06/27)

Embodiments of the invention are to compounds of formulae (A), (A'), methods, and compositions for use in the treatment of viral infections. More specifically embodiments of the invention aur 2 ', 4 ' -substituted nucleoside compounds useful for the treat

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 173379-73-2